Oregon jury says Johnson & Johnson must pay $260M in mesothelioma talc case

Johnson & Johnson is pursuing a “plan of reorganization” aimed at resolving 99.75% of the 60,000-plus talcum powder lawsuits the company faces. While that $6.5 billion settlement plan would clear the company of ovarian cancer claims, there’s still talc-related mesothelioma lawsuits for J&J to reckon with.